收费全文 | 930668篇 |
免费 | 67577篇 |
国内免费 | 1340篇 |
耳鼻咽喉 | 12957篇 |
儿科学 | 24363篇 |
妇产科学 | 23251篇 |
基础医学 | 132907篇 |
口腔科学 | 28242篇 |
临床医学 | 80541篇 |
内科学 | 183245篇 |
皮肤病学 | 19229篇 |
神经病学 | 72182篇 |
特种医学 | 36798篇 |
外国民族医学 | 79篇 |
外科学 | 152114篇 |
综合类 | 18044篇 |
现状与发展 | 1篇 |
一般理论 | 234篇 |
预防医学 | 61752篇 |
眼科学 | 21311篇 |
药学 | 72542篇 |
3篇 | |
中国医学 | 2166篇 |
肿瘤学 | 57624篇 |
2018年 | 8965篇 |
2017年 | 7028篇 |
2016年 | 7765篇 |
2015年 | 8866篇 |
2014年 | 11991篇 |
2013年 | 17501篇 |
2012年 | 24091篇 |
2011年 | 25045篇 |
2010年 | 14801篇 |
2009年 | 14276篇 |
2008年 | 24603篇 |
2007年 | 25698篇 |
2006年 | 26482篇 |
2005年 | 25426篇 |
2004年 | 24559篇 |
2003年 | 23603篇 |
2002年 | 23147篇 |
2001年 | 54728篇 |
2000年 | 56543篇 |
1999年 | 46951篇 |
1998年 | 10730篇 |
1997年 | 9465篇 |
1996年 | 9596篇 |
1995年 | 8927篇 |
1994年 | 8278篇 |
1993年 | 7594篇 |
1992年 | 35488篇 |
1991年 | 33912篇 |
1990年 | 32734篇 |
1989年 | 31870篇 |
1988年 | 28991篇 |
1987年 | 28249篇 |
1986年 | 26289篇 |
1985年 | 25144篇 |
1984年 | 17832篇 |
1983年 | 15143篇 |
1982年 | 7795篇 |
1981年 | 6774篇 |
1979年 | 15781篇 |
1978年 | 10599篇 |
1977年 | 9053篇 |
1976年 | 7871篇 |
1975年 | 8628篇 |
1974年 | 10466篇 |
1973年 | 9858篇 |
1972年 | 9357篇 |
1971年 | 8852篇 |
1970年 | 8426篇 |
1969年 | 7923篇 |
1968年 | 7200篇 |
Interstitial lung disease (ILD) represents a significant cause of morbidity and mortality in systemic sclerosis (SSc). The purpose of this study was to examine recirculating lymphocytes from SSc patients for potential biomarkers of interstitial lung disease (ILD). Peripheral blood mononuclear cells (PBMCs) were isolated from patients with SSc and healthy controls enrolled in the Vanderbilt University Myositis and Scleroderma Treatment Initiative Center cohort between 9/2017–6/2019. Clinical phenotyping was performed by chart abstraction. Immunophenotyping was performed using both mass cytometry and fluorescence cytometry combined with t-distributed stochastic neighbor embedding analysis and traditional biaxial gating. This study included 34 patients with SSc-ILD, 14 patients without SSc-ILD, and 25 healthy controls. CD21lo/neg cells are significantly increased in SSc-ILD but not in SSc without ILD (15.4 ± 13.3% vs. 5.8 ± 0.9%, p = 0.002) or healthy controls (5.0 ± 0.5%, p < 0.0001). While CD21lo/neg B cells can be identified from a single biaxial gate, tSNE analysis reveals that the biaxial gate is comprised of multiple distinct subsets, all of which are increased in SSc-ILD. CD21lo/neg cells in both healthy controls and SSc-ILD are predominantly tBET positive and do not have intracellular CD21. Immunohistochemistry staining demonstrated that CD21lo/neg B cells diffusely infiltrate the lung parenchyma of an SSc-ILD patient. Additional work is needed to validate this biomarker in larger cohorts and longitudinal studies and to understand the role of these cells in SSc-ILD.
相似文献Areas covered: This review summarizes the evolution of renal mass biopsy to its current state with respect to outcomes, indications, and clinical guidelines.
Expert opinion: With improved understanding of differential biological potential of renal cortical neoplasms combined with technical improvements in diagnostic yield and accuracy, utilization of renal mass biopsy is becoming an important adjunct to patient care in a broad range of clinical scenarios, including active surveillance, thermal ablation, and use of primary systemic therapy in localized and advanced settings. 相似文献
Methods: Two previously published datasets (n?=?153 and n?=?641, respectively) from outpatient neuropsychological evaluations were used to test Dunham and Denney’s algorithm, and to assess concordance of failure rates with the Test of Memory Malingering and the forced choice measure of the California Verbal Learning Test, two commonly used performance validity tests.
Results: In both datasets, none of the four cutoff scores for failure on the MSVT (70%, 75%, 80%, or 85%) identified a poor validity group with proportionally aligned failure rates on other freestanding measures of performance validity. Additionally, the protocols with probable impairment did not differ from those with poor validity on cognitive measures.
Conclusions: Despite what appeared to be a promising approach to evaluating failure on the easy MSVT subtests when clinical data are unavailable (as recommended in the advanced interpretation program, or advanced interpretation [AI], of the MSVT), the current findings indicate the AI remains the gold standard for doing so. Future research should build on this effort to address shortcomings in measures of effort in neuropsychological evaluations. 相似文献